Buyer for infectious disease CRO in Europe

Company to buy

• Size: Medium 
• Sales: 10 – 50 million EUR
• Location: Europe
• Reason for acquisition: The management wants to expand their business in Europe
• #CFIE PHB238

Overview of buyer for infectious disease CRO in Europe

This CRO is a full-service clinical research service provider to pharmaceutical, biotechnology, and medical device companies. Foundationally, it is headquartered in the United States and has offices around the world.

Profile (strategy) of buyer for infectious disease CRO in Europe

Essentially, this CRO is a full-service clinical research service provider to pharmaceutical, biotechnology, and medical device companies. Notably, it was founded about 50 years ago in America and now has a presence in over 70 countries across the world.

Chiefly, this CRO is also a leader in the use of innovative technologies to improve the efficiency and effectiveness of clinical trials. For example, it uses electronic data capture (EDC) systems to collect and manage clinical trial data. In particular, EDC systems help to reduce the risk of errors and improve data quality.

Overall, the CRO offers a wide range of services, including clinical trial design and management, regulatory affairs, and data management. Equally important, are statistical analysis, medical monitoring, pharmacovigilance, and site management. In addition, its team includes experienced and qualified clinical research professionals who are committed to helping their clients bring new drugs and devices to market safely and efficiently. Critically, the company has had a significant impact on the global health community. For instance, it has conducted clinical trials for a wide range of medical products, including vaccines, drugs, and medical devices. Above all, the CRO’s work has helped to improve the health of millions of people around the world.

Altogether, the group is well-positioned to continue to be a leader in the CRO industry, mainly in the infectious disease area. Significantly, its strong team encompasses over 200 experienced professionals. Furthermore, it has a global office network and a commitment to using innovative technologies.

Activities and products of suitable targets

In the coming years, the CRO is focused on several key areas for growth. More specifically, these areas include expanding its global footprint, expanding its service offerings, and developing new technologies.

At this time, the buyer is seeking a target company with expertise in clinical trials in the infectious disease area. In particular, the acquisition of a target with experience in related areas would be a strategic opportunity for the buyer company. Additionally, the buyer company could expand its service range and become an even more important player in the European market.

Highlights

• Full-service CRO with a global presence
• Wide range of services, including clinical trial design and management, regulatory affairs, data management and statistical analysis, medical monitoring, pharmacovigilance, and site management
• Team of experienced and qualified clinical research professionals
• Leader in the use of innovative technologies to improve the efficiency and effectiveness of clinical trials
• Committed to conducting ethical and responsible clinical research
• Significant impact on the global health community
• Well-positioned to continue to be a leader in the CRO industry

More information on this buyer for infectious disease CRO in Europe

Please get in touch if you are interested in learning more about this buyer for infectious disease CRO in Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.